Correlation Between Dadi Early and Maxigen Biotech

Can any of the company-specific risk be diversified away by investing in both Dadi Early and Maxigen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dadi Early and Maxigen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dadi Early Childhood Education and Maxigen Biotech, you can compare the effects of market volatilities on Dadi Early and Maxigen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dadi Early with a short position of Maxigen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dadi Early and Maxigen Biotech.

Diversification Opportunities for Dadi Early and Maxigen Biotech

-0.67

Correlation Coefficient

Dadi Early  Maxigen Biotech

Excellent diversification

The 3 months correlation between Dadi and Maxigen is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Dadi Early Childhood Education and Maxigen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maxigen Biotech and Dadi Early is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dadi Early Childhood Education are associated (or correlated) with Maxigen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maxigen Biotech has no effect on the direction of Dadi Early i.e., Dadi Early and Maxigen Biotech go up and down completely randomly.

Pair Corralation between Dadi Early and Maxigen Biotech

Assuming the 90 days trading horizon Dadi Early Childhood Education is expected to under-perform the Maxigen Biotech. In addition to that, Dadi Early is 1.32 times more volatile than Maxigen Biotech. It trades about -0.05 of its total potential returns per unit of risk. Maxigen Biotech is currently generating about 0.16 per unit of volatility. If you would invest  4,280  in Maxigen Biotech on October 27, 2024 and sell it today you would earn a total of  750.00  from holding Maxigen Biotech or generate 17.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Dadi Early Childhood Education  vs.  Maxigen Biotech

Dadi Early Childhood

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dadi Early Childhood Education has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Maxigen Biotech

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Maxigen Biotech are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Maxigen Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dadi Early and Maxigen Biotech

The main advantage of trading using opposite Dadi Early and Maxigen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dadi Early position performs unexpectedly, Maxigen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maxigen Biotech will offset losses from the drop in Maxigen Biotech's long position.

The idea behind Dadi Early Childhood Education and Maxigen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.